Clinical Trials Browser

Phase 4 × Lung Neoplasms × Olanzapine × Clear all

NCT03571126 2021-07-13

Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

Phase 4 Unknown

Lung Neoplasms, Vomiting